ABOUT THE PRODUCT
Helio Genomics’ core offering is a proprietary AI-driven technology platform for early cancer detection. Utilizing a simple blood draw, our platform analyzes multi-modal and multi-omics data to identify biomarkers indicative of cancer, enabling earlier diagnosis and treatment.
Information is owner-confirmed
Last updated 4 months ago
Price range